GlassScriptPhysician profile
Harry Lockstadt
NPI 1962471532
$8,923.78
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,678 · 2020: $3,012 · 2021: $1,048 · 2022: $2,142 · 2023: $43.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $3,564.13 | 2019-2022 | |
| Spineology INC. | $3,328.75 | 2019-2022 | |
| Integrity Implants INC. | $571.28 | 2021-2022 | |
| Smith+Nephew, INC. | $272.73 | 2022 | |
| Depuy Synthes Sales INC. | $243.94 | 2019-2021 | |
| Providence Medical Technology, INC. | $171.09 | 2019-2023 | |
| Stryker Corporation | $142.79 | 2022 | |
| Alevio, LLC | $124.51 | 2019 | |
| Medical Device Business Services, INC. | $93.06 | 2019 | |
| Medtronic USA, INC. | $79.33 | 2019 | |
| Orthofix Medical, INC. | $73.41 | 2019 | |
| Abbott Laboratories | $58.83 | 2019-2022 | |
| Horizon Therapeutics Plc | $54.50 | 2022 | |
| Pacira Therapeutics, INC. | $42.25 | 2019-2021 | |
| Medtronic, INC. | $31.13 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $29.29 | 2020 | |
| Nevro Corp. | $15.82 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.79 | 2022 | |
| Flowonix Medical Incorporated | $13.15 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$1,024,991.52 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Lockstadt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.